Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medifast Inc Q2 2013 Guidance Below Analysts' Estimates; Reiterates FY 2013 Guidance


Wednesday, 8 May 2013 04:06pm EDT 

Medifast Inc announced that for the second quarter of 2013, it expects net revenue to be in the range of $98.0 to $102.0 million and earnings per diluted share (EPS) to be in the range of $0.45 to $0.50. For fiscal 2013, the Company reiterated its previous guidance of net revenue to be in the range of $385 to $400 million and EPS in the range of $1.70 to $1.80. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $102.8 million and EPS of $0.55 for the second quarter of 2013; revenue of $389 million and EPS of $1.77 for fiscal 2013. 

Company Quote

33.71
0.17 +0.51%
3:14pm EDT